56 related articles for article (PubMed ID: 25475994)
1. An in vitro approach to investigate ocular metabolism of a topical, selective β1-adrenergic blocking agent, betaxolol.
Bushee JL; Dunne CE; Argikar UA
Xenobiotica; 2015 May; 45(5):396-405. PubMed ID: 25475994
[TBL] [Abstract][Full Text] [Related]
2. Ocular-specific chemical delivery systems of betaxolol for safe local treatment of glaucoma.
Farag HH; Wu WM; Barros MD; Somogyi G; Prokai L; Bodor N
Drug Des Discov; 1997 Aug; 15(2):117-30. PubMed ID: 9342554
[TBL] [Abstract][Full Text] [Related]
3. Ocular Metabolism of Levobunolol: Historic and Emerging Metabolic Pathways.
Argikar UA; Dumouchel JL; Dunne CE; Saran C; Cirello AL; Gunduz M
Drug Metab Dispos; 2016 Aug; 44(8):1304-12. PubMed ID: 27190057
[TBL] [Abstract][Full Text] [Related]
4. Topical ocular pharmacokinetics and bioavailability for a cocktail of atenolol, timolol and betaxolol in rabbits.
Fayyaz A; Ranta VP; Toropainen E; Vellonen KS; Valtari A; Puranen J; Ruponen M; Gardner I; Urtti A; Jamei M; Del Amo EM
Eur J Pharm Sci; 2020 Dec; 155():105553. PubMed ID: 32946960
[TBL] [Abstract][Full Text] [Related]
5. In vitro ocular metabolism and bioactivation of ketoconazole in rat, rabbit and human.
Cirello AL; Dumouchel JL; Gunduz M; Dunne CE; Argikar UA
Drug Metab Pharmacokinet; 2017 Apr; 32(2):121-126. PubMed ID: 28139372
[TBL] [Abstract][Full Text] [Related]
6. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
Fukano Y; Kawazu K
Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
[TBL] [Abstract][Full Text] [Related]
7. Levobetaxolol (Betaxon) and other beta-adrenergic antagonists: preclinical pharmacology, IOP-lowering activity and sites of action in human eyes.
Sharif NA; Xu SX; Crider JY; McLaughlin M; Davis TL
J Ocul Pharmacol Ther; 2001 Aug; 17(4):305-17. PubMed ID: 11572462
[TBL] [Abstract][Full Text] [Related]
8. Effects of the beta1-selective adrenergic antagonist betaxolol on electroretinography in the perfused cat eye.
Uji Y; Kuze M; Matubara H; Doi M; Sasoh M
Doc Ophthalmol; 2003 Jan; 106(1):37-41. PubMed ID: 12675484
[TBL] [Abstract][Full Text] [Related]
9. Primary open-angle glaucoma patients characterized by ocular vasospasm demonstrate a different ocular vascular response to timolol versus betaxolol.
Evans DW; Harris A; Cantor LB
J Ocul Pharmacol Ther; 1999 Dec; 15(6):479-87. PubMed ID: 10609770
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of betaxolol in ocular tissues of patients with glaucoma and normal monkeys after 1 month of topical ocular administration.
Holló G; Whitson JT; Faulkner R; McCue B; Curtis M; Wieland H; Chastain J; Sanders M; DeSantis L; Przydryga J; Dahlin DC
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):235-40. PubMed ID: 16384968
[TBL] [Abstract][Full Text] [Related]
11. The effect of topical beta-adrenoceptor blocking agents on pulsatile ocular blood flow.
Morsman CD; Bosem ME; Lusky M; Weinreb RN
Eye (Lond); 1995; 9 ( Pt 3)():344-7. PubMed ID: 7556745
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term topical betaxolol on tissue circulation in the iris and optic nerve head.
Araie M; Muta K
Exp Eye Res; 1997 Feb; 64(2):167-72. PubMed ID: 9176049
[TBL] [Abstract][Full Text] [Related]
13. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers.
Olateju SO; Ajayi AA
Eye (Lond); 1999 Dec; 13 ( Pt 6)():758-63. PubMed ID: 10707140
[TBL] [Abstract][Full Text] [Related]
14. Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity.
Osborne NN; Wood JP; Cupido A; Melena J; Chidlow G
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1456-64. PubMed ID: 11980861
[TBL] [Abstract][Full Text] [Related]
15. Effect of betaxolol on impaired choroidal blood flow after intravitreal injection of endothelin-1 in albino rabbits.
Kim JH; Kim DM; Park WC
J Ocul Pharmacol Ther; 2002 Jun; 18(3):203-9. PubMed ID: 12099541
[TBL] [Abstract][Full Text] [Related]
16. The 5-HT(1A)Receptor agonist 8-OH-DPAT lowers intraocular pressure in normotensive NZW rabbits.
Chidlow G; Nash MS; De Santis LM; Osborne NN
Exp Eye Res; 1999 Dec; 69(6):587-93. PubMed ID: 10620387
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of befunolol, betaxolol and timolol eye drops.
Dorigo MT; Cerin O; Fracasso G; Altafini R
Int J Clin Pharmacol Res; 1990; 10(3):163-6. PubMed ID: 1977708
[TBL] [Abstract][Full Text] [Related]
18. [The effect of the beta 1 selective beta blocker, betaxolol, on metabolism in type II diabetics].
Janka HU; Ziegler AG; Larrat V; Mehnert H
Arzneimittelforschung; 1989 May; 39(5):615-7. PubMed ID: 2569309
[TBL] [Abstract][Full Text] [Related]
19. Effects of antiglaucoma drugs on ocular hemodynamics in healthy volunteers.
Schmetterer L; Strenn K; Findl O; Breiteneder H; Graselli U; Agneter E; Eichler HG; Wolzt M
Clin Pharmacol Ther; 1997 May; 61(5):583-95. PubMed ID: 9164420
[TBL] [Abstract][Full Text] [Related]
20. Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina.
Osborne NN; DeSantis L; Bae JH; Ugarte M; Wood JP; Nash MS; Chidlow G
Exp Eye Res; 1999 Sep; 69(3):331-42. PubMed ID: 10471341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
